Gerard Champi

Business news, market intelligence, and global industry analysis.

The Latest

Bally’s Corporation (NYSE: BALY) eyes evoke plc (LSE: EVOK): why a William Hill deal would reshape UK gambling

Why Lockheed Martin’s $101.6 m Army award matters more than its size suggests for LMT stock

Representative image of targeted protein degradation research as SK Life Science Labs presents new preclinical p300 and PRMT5 cancer data at AACR 2026.

Why SK Life Science Labs’ AACR 2026 data could put targeted protein degradation back in the oncology spotlight

Why Cerebras’ IPO filing looks less like a chip listing and more like an AI infrastructure wager

Peoples Financial Services (NASDAQ: PFIS) earnings jump in 2025 on merger synergies, but Q4 hit by investment losses

Peoples Financial Services Corp. earnings jumped in 2025 on merger synergies and margin gains. Find out how Q4 losses are setting up stronger 2026 returns.

μFR system
αvβ6-integrin
α4β7 integrin
ZYUS Life Sciences
Zyrtec
Zyprexa Zydis
Zynga
Zynext Ventures USA LLC
Zynext Ventures
Zynex

February 1, 2026